DermaBind SL is an amnion derived allograft.
INTENDED USES: Intended use of DermaBind SL™ includes the management of wounds, such as, partial and full thickness wounds, pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds, trauma wounds, and draining wounds.
CLAIMED BENEFITS: The DermaBind process does not use unnecessary chemicals, antibiotics or preservatives and is never frozen. The finished product is physician-friendly, durable, easily applied to a wound and can be stored at room temperature for up to 3 years.
OPTIONS: Per Square Centimeter
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care